Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 07, 2024

BUY
$8.44 - $13.47 $179,620 - $286,668
21,282 Added 4.46%
498,448 $4.58 Million
Q1 2023

May 12, 2023

BUY
$8.44 - $13.47 $179,620 - $286,668
21,282 Added 4.46%
498,448 $4.58 Million
Q4 2022

Oct 07, 2024

BUY
$9.71 - $15.86 $4.63 Million - $7.57 Million
477,166 New
477,166 $4.87 Million
Q4 2022

Feb 10, 2023

BUY
$9.71 - $15.86 $4.63 Million - $7.57 Million
477,166 New
477,166 $4.87 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $918M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.